Intranasal administration of CART 3 days after MCAO increased brain CART levels, up-regulated BDNF expression, enhanced NSCs survival, proliferation and migration, improved neurological function, and promoted nerve regeneration in stroke animals (Luo et al., 2013). The gene discussed is BDNF; the disease is stroke disorder.